Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Prothena Corp (PRTA)

Prothena Corp (PRTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 430,888
  • Shares Outstanding, K 39,897
  • Annual Sales, $ 960 K
  • Annual Income, $ -155,650 K
  • 60-Month Beta 2.20
  • Price/Sales 427.80
  • Price/Cash Flow N/A
  • Price/Book 1.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.65
  • Number of Estimates 2
  • High Estimate -0.61
  • Low Estimate -0.68
  • Prior Year -0.59
  • Growth Rate Est. (year over year) -10.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.79 +36.20%
on 10/21/19
11.96 -11.27%
on 11/19/19
+2.82 (+36.20%)
since 10/18/19
3-Month
6.71 +58.12%
on 08/26/19
11.96 -11.27%
on 11/19/19
+2.92 (+37.97%)
since 08/20/19
52-Week
6.71 +58.12%
on 08/26/19
14.77 -28.17%
on 03/04/19
-0.99 (-8.53%)
since 11/20/18

Most Recent Stories

More News
Prothena (PRTA) Reports Narrower-than-Expected Loss in Q3

Prothena (PRTA) posts a narrower Q3 loss while sales surpass estimates.

RHHBY : 38.1900 (-0.29%)
CELG : 107.98 (-0.14%)
PRTA : 10.76 (-0.37%)
LCI : 8.92 (-0.89%)
Prothena (PRTA) Reports Q3 Loss, Tops Revenue Estimates

Prothena (PRTA) delivered earnings and revenue surprises of 9.26% and 36.67%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

PRTA : 10.76 (-0.37%)
Prothena Reports Third Quarter 2019 Financial Results and Provides R&D Update

- Net cash used in operating and investing activities was $9.2 million in the third quarter and $38.9 million for the first nine months of 2019; quarter-end cash and restricted cash position of $393.0...

PRTA : 10.76 (-0.37%)
Shares of PRTA Up 4.9% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Prothena Corp Pl (NASDAQ:PRTA) on August 29th, 2019 at $8.95. In approximately 2 months, Prothena Corp Pl has returned 4.86% as of today's recent price of $9.38.

PRTA : 10.76 (-0.37%)
Prothena to Report Third Quarter 2019 Financial Results on November 5

DUBLIN, Ireland, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical-stage neuroscience company, will announce financial results for the third quarter and first nine...

PRTA : 10.76 (-0.37%)
Labaton Sucharow LLP and Levi & Korsinsky LLP Announce Proposed Class Action Settlement on Behalf of Purchasers of Ordinary Shares of Prothena Corporation plc in In re Prothena Corporation plc Securities Litigation, No. 1:18-cv-06425-ALC

Labaton Sucharow LLP and Levi & Korsinsky LLP announce that the United States District Court for the Southern District of New York has approved the following announcement of a proposed class action settlement...

PRTA : 10.76 (-0.37%)
Why Is Prothena (PRTA) Down 8.9% Since Last Earnings Report?

Prothena (PRTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PRTA : 10.76 (-0.37%)
Prothena Corp Pl Down 22.6% Since SmarTrend Downtrend Call (PRTA)

SmarTrend identified a Downtrend for Prothena Corp Pl (NASDAQ:PRTA) on August 5th, 2019 at $8.82. In approximately 3 weeks, Prothena Corp Pl has returned 22.56% as of today's recent price of $6.83.

PRTA : 10.76 (-0.37%)
Prothena (PRTA) Reports Q2 Loss, Lags Revenue Estimates

Prothena (PRTA) delivered earnings and revenue surprises of 28.57% and -22.33%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

PRTA : 10.76 (-0.37%)
Prothena Reports Second Quarter 2019 Financial Results and Provides R&D Update

- Net cash used in operating and investing activities was $12.2 million in the second quarter and $29.7 million for the first six months of 2019; quarter-end cash and restricted cash position of $402.2...

PRTA : 10.76 (-0.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade PRTA with:

Business Summary

Prothena Corporation plc is a biotechnology company focused on the discovery and development of therapeutic monoclonal antibodies for disease-causing proteins. The Company is developing the following programs: NEOD001 for Amyloidosis, NEOD002 for Parkinson's disease, MCAM for Inflammatory disease and...

See More

Key Turning Points

2nd Resistance Point 12.37
1st Resistance Point 11.59
Last Price 10.76
1st Support Level 10.39
2nd Support Level 9.98

See More

52-Week High 14.77
Fibonacci 61.8% 11.69
Last Price 10.76
Fibonacci 50% 10.74
Fibonacci 38.2% 9.79
52-Week Low 6.71

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar